A research team from the University of Basel has managed to synthesize simple, environmentally sensitive cells complete with artificial organelles.… Read More »Synthetic cells emulate natural cellular communication
Even treated with the most advanced therapies, patients with glioblastoma (an aggressive brain cancer) typically survive less than two years… Read More »Researchers make glioblastoma cells visible to attack immune cells
Researchers at UCLA’s Samueli School of Engineering and the University of Rome Tor Vergata in Italy have developed synthetic genes… Read More »Synthetic genes designed to mimic how cells build tissues and structures
Cutting off cancer cells’ access to fat may help a specific type of cancer treatment work more effectively, reports a… Read More »Starving cancer cells of fat may improve cancer treatment
A team from Kumamoto University has made a groundbreaking discovery in the field of aging and inflammation. Japan’s aging population… Read More »Researchers identify key enzyme in aging cells to promote healthy aging
Researchers at the University of Rochester have demonstrated a non-invasive method using BL-OG, or bioluminescent optogenetics, which harnesses light to… Read More »Activate brain cells using the power of light
Glioblastoma is the most common and aggressive primary brain tumor, with an average survival after diagnosis of less than two… Read More »Programming cells to attack brain tumors
A classic psychedelic similar to LSD, psilocybin and mescaline has been found to activate a type of cell in the… Read More »Psychedelics excite hippocampal cells to reduce anxiety
Feverish temperatures accelerate metabolism, proliferation and immune cell activity, but also (in a particular subset of T cells) cause mitochondrial… Read More »Fever causes increased mitochondrial activity and damage in immune cells
By recruiting the immune system to fight tumor cells, immunotherapy has improved survival rates and offered hope to millions of… Read More »Drug bypasses immune suppressor cells to trigger immunotherapy